General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Responsibly tackling the challenging issues

Novartis is committed to tackling the many global health challenges through innovative approaches to research and development. We recognize that our efforts to push the boundaries of knowledge in the field of human health may give rise to ethical issues.

We are committed to upholding high standards of ethics across our business and to transparently setting out our position on these challenging issues. Novartis recognizes the importance of informed stakeholder debate on such issues and welcomes the opportunity to engage in constructive dialogue.